CAS ID: | 58-32-2 |
Molecular Formula: | C24H40N8O4 |
Molecular Weight: | 504.6 g/mol |
Monoisotopic Mass: | 504.3173 g/mol |
Class: | Small Molecule |
Natural Product: | No |
Other Names: | MODAPLATE | IV PERSANTINE | CEREBROVASE 25 | ATTIA | CEREBROVASE 100 | PYRIDANTIN | PERSANTINE | PERSANTIN RET | OFCRAM PR | DIPYRIDAMOLE | PERSANTIN | VASYROL | RA-8 |
Analysis: | Drug repositioning mechanism analysis |
Reference Record 1
PubMed ID | 11380836 | Target ID | |
Uniprot ID | Name | ||
Model | vitro,rat | Fibrosis Disease | Peritoneal fibrosis |
Process I | |||
Process II | cells proliferation | ||
Process III | |||
Mechanism |
Trial Record 1
ClinicalTrial ID | NCT02247414 | Disease | Liver fibrosis |
Phase | Phase 4 | Status | Completed |
First Received | September 25, 2014 | Last Verified | November 6, 2017 |
Sponsor | Yangzhou University |
Trial Record 2
ClinicalTrial ID | NCT02238444 | Disease | Liver fibrosis |
Phase | Phase 4 | Status | Recruiting |
First Received | September 12, 2014 | Last Verified | January 1, 2019 |
Sponsor | Yangzhou University |